WO2010148314A3 - Preparation of esomeprazole and its pharmaceutically acceptable salts - Google Patents
Preparation of esomeprazole and its pharmaceutically acceptable salts Download PDFInfo
- Publication number
- WO2010148314A3 WO2010148314A3 PCT/US2010/039187 US2010039187W WO2010148314A3 WO 2010148314 A3 WO2010148314 A3 WO 2010148314A3 US 2010039187 W US2010039187 W US 2010039187W WO 2010148314 A3 WO2010148314 A3 WO 2010148314A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- esomeprazole
- preparation
- pharmaceutically acceptable
- acceptable salts
- processes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Abstract
Processes for the preparation of esomeprazole and its pharmaceutically acceptable salts.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1452CH2009 | 2009-06-19 | ||
IN1452/CHE/2009 | 2009-06-19 | ||
US29261710P | 2010-01-06 | 2010-01-06 | |
US61/292,617 | 2010-01-06 | ||
IN573CH2010 | 2010-03-05 | ||
IN573/CHE/2010 | 2010-03-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010148314A2 WO2010148314A2 (en) | 2010-12-23 |
WO2010148314A3 true WO2010148314A3 (en) | 2011-05-26 |
Family
ID=43357070
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2010/039187 WO2010148314A2 (en) | 2009-06-19 | 2010-06-18 | Preparation of esomeprazole and its pharmaceutically acceptable salts |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2010148314A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102993181B (en) * | 2012-12-26 | 2014-07-23 | 山东大学 | Preparation method of esomeprazole and preparation method of esomeprazole salt |
CN104530003A (en) * | 2014-06-10 | 2015-04-22 | 广东东阳光药业有限公司 | Preparation method of salts of pyridylmethyl sulfinyl-1H-benzimidazole compounds |
CN106366070B (en) * | 2016-08-10 | 2019-06-11 | 上海万巷制药有限公司 | A kind of preparation method of high-purity esomeprazole sodium |
CN110305108B (en) * | 2019-07-10 | 2022-05-03 | 湖南协创药品开发有限公司 | Preparation method of esomeprazole magnesium |
CN111072633A (en) * | 2019-12-19 | 2020-04-28 | 山东达因海洋生物制药股份有限公司 | Preparation method of esomeprazole magnesium trihydrate |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007013743A1 (en) * | 2005-07-28 | 2007-02-01 | Hanmi Pharm. Co., Ltd. | Method of preparing esomeprazole and salts thereof |
EP1801110A1 (en) * | 2005-12-22 | 2007-06-27 | KRKA, tovarna zdravil, d.d., Novo mesto | Esomeprazole arginine salt |
EP1847538A1 (en) * | 2006-04-21 | 2007-10-24 | Dipharma Francis S.r.l. | A process for the preparation of pyridine compounds |
US20090076277A1 (en) * | 2006-10-30 | 2009-03-19 | Dipharma Francis S.R.L. | Process for the preparation of pyridine-methylsulfinyl compounds |
-
2010
- 2010-06-18 WO PCT/US2010/039187 patent/WO2010148314A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007013743A1 (en) * | 2005-07-28 | 2007-02-01 | Hanmi Pharm. Co., Ltd. | Method of preparing esomeprazole and salts thereof |
EP1801110A1 (en) * | 2005-12-22 | 2007-06-27 | KRKA, tovarna zdravil, d.d., Novo mesto | Esomeprazole arginine salt |
EP1847538A1 (en) * | 2006-04-21 | 2007-10-24 | Dipharma Francis S.r.l. | A process for the preparation of pyridine compounds |
US20090076277A1 (en) * | 2006-10-30 | 2009-03-19 | Dipharma Francis S.R.L. | Process for the preparation of pyridine-methylsulfinyl compounds |
Also Published As
Publication number | Publication date |
---|---|
WO2010148314A2 (en) | 2010-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009084024A3 (en) | A process for the preparation of r-sit agliptin and its pharmaceutically acceptable salts thereof | |
WO2010117738A3 (en) | Solid state forms of sitagliptin salts | |
EP2629975A4 (en) | Devices, systems, and methods for the fabrication of tissue | |
WO2012077136A3 (en) | Process for the preparation of benzimidazole derivatives and its salts | |
IL212339A (en) | Pyrrolobenzodiazepine derivatives and processes for the preparation thereof | |
AP2011005994A0 (en) | Methods for improving the dissolution profile of abiologically active material. | |
EP2424427A4 (en) | Highly reliable ingestible event markers and methods for using the same | |
EP2220093A4 (en) | Processes for the preparation of sitagliptin and pharmaceutically acceptable salts thereof | |
ZA201300100B (en) | Indolizine derivatives,process for the preparation thereof and therapeutic use thereof | |
WO2011133504A3 (en) | Nanozymes, methods of making nanozymes, and methods of using nanozymes | |
WO2012068441A3 (en) | Intedanib salts and solid state forms thereof | |
WO2010056656A3 (en) | Preparation of crystalline palonosetron hydrochloride | |
WO2011076212A3 (en) | Processes for the manufacture of a pharmaceutically active agent | |
WO2011079193A3 (en) | Preparation of bendamustine and its salts | |
WO2011069076A3 (en) | Sustained release donepezil formulations | |
EP2398511B8 (en) | Medical device and method for making the same | |
IL212942A (en) | Rifamycin derivatives, process for their preparation, pharmaceutical compositions comprising the same and uses thereof | |
EP2600880A4 (en) | Soybean extracts for the treatment of hepatic disorders | |
WO2010148314A3 (en) | Preparation of esomeprazole and its pharmaceutically acceptable salts | |
EP2709455A4 (en) | Processes for the preparation of 5-azaspiro[2.4]heptane-6-carboxylic acid and its derivatives | |
WO2011023954A3 (en) | Polymorphic forms of manidipine | |
HU1000565D0 (en) | Process for the preparation of pharmaceutically active compound and intermediers | |
SI2331098T1 (en) | Methods for the administration of iloperidone | |
WO2010148209A3 (en) | Preparation of montelukast | |
WO2011107921A3 (en) | Modified release composition of milnacipran |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10790272 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 9496/CHENP/2011 Country of ref document: IN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 10790272 Country of ref document: EP Kind code of ref document: A2 |